Suanfarma Suanfarma

X

CAS 156755-23-6 manufacturers and suppliers on PharmaCompass

PharmaCompass
CAS 156755-23-6
Also known as: 156755-23-6, 6-bromo-3,4-dihydro-4-phenyl-2h-1-benzopyran-2-one, 6-bromo-4-phenyl-3,4-dihydrochromen-2-one, Ec 923-250-0, Schembl725197, 6-bromo-4-phenyl-2-chromanone
Molecular Formula
C15H11BrO2
Molecular Weight
303.15  g/mol
InChI Key
KFKFQGCDFMGUCH-UHFFFAOYSA-N

1 2D Structure

CAS 156755-23-6

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
6-bromo-4-phenyl-3,4-dihydrochromen-2-one
2.1.2 InChI
InChI=1S/C15H11BrO2/c16-11-6-7-14-13(8-11)12(9-15(17)18-14)10-4-2-1-3-5-10/h1-8,12H,9H2
2.1.3 InChI Key
KFKFQGCDFMGUCH-UHFFFAOYSA-N
2.1.4 Canonical SMILES
C1C(C2=C(C=CC(=C2)Br)OC1=O)C3=CC=CC=C3
2.2 Synonyms
2.2.1 Depositor-Supplied Synonyms

1. 156755-23-6

2. 6-bromo-3,4-dihydro-4-phenyl-2h-1-benzopyran-2-one

3. 6-bromo-4-phenyl-3,4-dihydrochromen-2-one

4. Ec 923-250-0

5. Schembl725197

6. 6-bromo-4-phenyl-2-chromanone

7. Dtxsid80387841

8. Cs-b0084

9. Mfcd03686976

10. Akos027383084

11. (+/-)-6-bromo-4-phenylchroman-2-one

12. 6-bromo-4-phenyl-3,4-dihydro-coumarine

13. Cs-14111

14. A18245

15. 755b236

16. Sr-01000250260

17. Sr-01000250260-1

18. 2h-1-benzopyran-2-one,6-bromo-3,4-dihydro-4-phenyl-,( Inverted Exclamation Marka)-

2.3 Create Date
2005-07-29
3 Chemical and Physical Properties
Molecular Weight 303.15 g/mol
Molecular Formula C15H11BrO2
XLogP33.8
Hydrogen Bond Donor Count0
Hydrogen Bond Acceptor Count2
Rotatable Bond Count1
Exact Mass301.99424 g/mol
Monoisotopic Mass301.99424 g/mol
Topological Polar Surface Area26.3 Ų
Heavy Atom Count18
Formal Charge0
Complexity312
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count1
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
Flag India
Digital Content Digital Content
156755-35-0
Fesoterodine
Malladi Drugs & Pharmaceuticals Ltd was founded in 1980 by microbiologist Mr. M L N Sastry. Within a few ...
Malladi Drugs & Pharmaceuticals Ltd was founded in 1980 by microbiologist Mr. M L N Sastry. Within a few years, Malladi established itself as a leader in manufacturing ephedrine and pseudoephedrine salts. Today, it is the leading manufacturer of APIs in the cough and cold segment. It also has a dominant presence in several therapeutic segments like antihistamines, anti-convulsants, anti-depressants and anxiolytics (CNS). Malladi exports its products to around 60 countries and over 85% of its revenue is generated from exports. Its manufacturing facilities have been approved by the FDA, EDQM, KFDA, TGA and various other regulatory agencies.
Malladi Company Banner

India Med Expo

Not Confirmed

envelop Contact Supplier
Flag India
Digital Content Digital Content
156755-25-8
Fesoterodine
Malladi Drugs & Pharmaceuticals Ltd was founded in 1980 by microbiologist Mr. M L N Sastry. Within a few ...
Malladi Drugs & Pharmaceuticals Ltd was founded in 1980 by microbiologist Mr. M L N Sastry. Within a few years, Malladi established itself as a leader in manufacturing ephedrine and pseudoephedrine salts. Today, it is the leading manufacturer of APIs in the cough and cold segment. It also has a dominant presence in several therapeutic segments like antihistamines, anti-convulsants, anti-depressants and anxiolytics (CNS). Malladi exports its products to around 60 countries and over 85% of its revenue is generated from exports. Its manufacturing facilities have been approved by the FDA, EDQM, KFDA, TGA and various other regulatory agencies.
Malladi Company Banner

India Med Expo

Not Confirmed

envelop Contact Supplier
Flag India
Digital Content Digital Content
156755-24-7
Fesoterodine
Malladi Drugs & Pharmaceuticals Ltd was founded in 1980 by microbiologist Mr. M L N Sastry. Within a few ...
Malladi Drugs & Pharmaceuticals Ltd was founded in 1980 by microbiologist Mr. M L N Sastry. Within a few years, Malladi established itself as a leader in manufacturing ephedrine and pseudoephedrine salts. Today, it is the leading manufacturer of APIs in the cough and cold segment. It also has a dominant presence in several therapeutic segments like antihistamines, anti-convulsants, anti-depressants and anxiolytics (CNS). Malladi exports its products to around 60 countries and over 85% of its revenue is generated from exports. Its manufacturing facilities have been approved by the FDA, EDQM, KFDA, TGA and various other regulatory agencies.
Malladi Company Banner

India Med Expo

Not Confirmed

envelop Contact Supplier
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY